ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval

ViroCell Biologics announces that the Company is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.

Scroll to Top